
Shares of Kleenex tissue maker Kimberly-Clark KMB.N down 3.5% at $135.27% in early trading
Co slashes annual profit forecast, warns broad-based tariffswill increase supply chain costs
Reports Q1 revenue below analysts' estimates; price reductions and demand slowdown hurt revenue of co's North America segment, its largest
However, Q1 adjusted profit beat estimates, according to data compiled by LSEG, helped by lower adjusted effective tax rate
The company now faces tough decisions: to raise prices and risk losing loyal customers, or absorb costs and damage profitability - eMarketer analyst Zak Stambor
Up to last close, stock had risen ~7% YTD